Fresenius Ebit from 2010 to 2026
| FMS Stock | USD 24.44 0.02 0.08% |
EBIT | First Reported 2000-03-31 | Previous Quarter 447.1 M | Current Value 476.5 M | Quarterly Volatility 197.6 M |
Check Fresenius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fresenius Medical's main balance sheet or income statement drivers, such as Interest Expense of 268.2 M, Total Revenue of 11.7 B or Gross Profit of 3.7 B, as well as many indicators such as Price To Sales Ratio of 1.47, Dividend Yield of 0.0123 or PTB Ratio of 0.96. Fresenius financial statements analysis is a perfect complement when working with Fresenius Medical Valuation or Volatility modules.
Fresenius | Ebit | Build AI portfolio with Fresenius Stock |
The evolution of Ebit for Fresenius Medical Care provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Fresenius Medical compares to historical norms and industry peers.
Latest Fresenius Medical's Ebit Growth Pattern
Below is the plot of the Ebit of Fresenius Medical Care over the last few years. It is Fresenius Medical's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fresenius Medical's overall financial position and show how it may be relating to other accounts over time.
| Ebit | 10 Years Trend |
|
Ebit |
| Timeline |
Fresenius Ebit Regression Statistics
| Arithmetic Mean | 1,952,771,153 | |
| Geometric Mean | 1,914,297,748 | |
| Coefficient Of Variation | 21.14 | |
| Mean Deviation | 341,571,115 | |
| Median | 1,923,583,098 | |
| Standard Deviation | 412,766,800 | |
| Sample Variance | 170376.4T | |
| Range | 1.5B | |
| R-Value | (0.45) | |
| Mean Square Error | 145216.3T | |
| R-Squared | 0.20 | |
| Significance | 0.07 | |
| Slope | (36,641,434) | |
| Total Sum of Squares | 2726022.9T |
Fresenius Ebit History
Other Fundumenentals of Fresenius Medical Care
About Fresenius Medical Financial Statements
Fresenius Medical shareholders use historical fundamental indicators, such as Ebit, to determine how well the company is positioned to perform in the future. Although Fresenius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Fresenius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Fresenius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| EBIT | 1.7 B | 1.6 B | |
| EBITDA | 3.7 B | 2.3 B | |
| Ebt Per Ebit | 0.68 | 0.58 | |
| Ebit Per Revenue | 0.08 | 0.15 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.